This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Dawson, D. Articles by Lushington, K. Search for Related Content PubMed PubMed Citation Articles by Dawson, D. Articles by Lushington, K. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Social Bookmarking                         What's this?

Effect of Sustained Nocturnal Transbuccal Melatonin Administration on Sleep and Temperature in Elderly Insomniacs

Centre for Sleep Research, Faculty of Humanities and Social Sciences, University of South Australia, Queen Elizabeth Hospital, Woodville Road, Woodville SA 5011, Australia

Naomi L. Rogers

Cameron J. van den Heuvel

David J. Kennaway

Department of Obstetrics and Gynecology, University of Adelaide, North Terrace, Adelaide SA 5005, Australia

Kurt Lushington

Centre for Sleep Research, Faculty of Humanities and Social Sciences, University of South Australia, Queen Elizabeth Hospital, Woodville Road, Woodville SA 5011, Australia

Previous research has suggested a role for the pineal hormone melatonin in the control of the body's sleep-wake and thermoregulatory systems. In the elderly population, there have been reports of decreased nighttime secretion of melatonin and suggestions that this may, in turn, be responsible for the increased incidence of sleep disorders reported by this age group. On this basis, it has been suggested that augmented nocturnal melatonin levels may improve sleep quality in age-related sleep disorders. Following screening assessments, 12 elderly (> 55 years) subjects with sleep maintenance insomnia were treated with either 0.5 mg transbuccal melatonin or a placebo for two sessions of 4 consecutive nights, at least 3 days apart. Subjects self-selected lights-out times, and sleep was assessed using standard polysomnographic (PSG) measures. Body temperature was measured continually from 2100 to 0700 h, and sleep quality was assessed from PSG variables measured. Nightly urine samples were assayed for the melatonin metabolite 6-sulfatoxy-melatonin (aMT.6S). Compared to the placebo, transbuccal melatonin administration significantly increased mean nocturnal aMT.6S excretion (mean ±SEM: 194.2 ± 16.5 vs. 42.5 ± 7.7 nmol). In addition, there was a significant reduction in core body temperature relative to the placebo condition (p < .05). However, sustained transbuccal melatonin treatment had no positive significant effect on any PSG measure of sleep quality. The results from the present study suggest that sustained nocturnal administration of melatonin, in the low pharmacological range, might be of limited clinical benefit in this subject population.

Key Words: transbuccal melatonin administration • elderly insomniacs • sleep • core temperature

Journal of Biological Rhythms, Vol. 13, No. 6, 532-538 (1998)
DOI: 10.1177/074873098129000354


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				F. L. Campos, F. P. da Silva-Junior, V. M. S. de Bruin, and P. F. C. de Bruin Melatonin Improves Sleep in Asthma: A Randomized, Double-blind, Placebo-controlled Study Am. J. Respir. Crit. Care Med., November 1, 2004; 170(9): 947 - 951. [Abstract] [Full Text] [PDF]

				D. R. Weaver and C. E. Capodice Postmortem Stability of Melatonin Receptor Binding and Clock-Relevant mRNAs in Mouse Suprachiasmatic Nucleus J Biol Rhythms, June 1, 2001; 16(3): 216 - 223. [Abstract] [PDF]